Content-Type: multipart/alternative;
 boundary="----=_NextPart_43787348.329277678517"
From: "Rieseberg, Loren" <loren.rieseberg@botany.ubc.ca>
To: "John M. Burke" <jmburke@uga.edu>
CC: Emily Marden <emily.marden@gmail.com>, Brent Hulke
	<Brent.Hulke@ARS.USDA.GOV>, Lisa Donovan <ldonovan@uga.edu>
Subject: Re: Key Genome BC Dates for Sunflower Project 
Thread-Topic: Key Genome BC Dates for Sunflower Project 
Thread-Index: AQHQSxeYg5i2LOHroUegwYcL7Duw9Jz2XwAA
Date: Wed, 18 Feb 2015 04:58:30 +0000
Message-ID: <85881F81-638C-4576-B720-FF88A3AB4ABF@mail.ubc.ca>
References: <D1092659.109E3%dcharest@genomebc.ca>
In-Reply-To: <D1092659.109E3%dcharest@genomebc.ca>
Accept-Language: en-US, en-CA
Content-Language: en-US
MIME-Version: 1.0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
Received-SPF: None (protection.outlook.com: botany.ubc.ca does not designate
 permitted sender hosts)
Authentication-Results: spf=none (sender IP is 142.103.117.142)
 smtp.mailfrom=loren.rieseberg@botany.ubc.ca; uga.edu; dkim=none (message not
 signed) header.d=none;uga.edu; dmarc=none action=none
 header.from=botany.ubc.ca;
X-Forefront-Antispam-Report: CIP:142.103.117.142;CTRY:CA;IPV:NLI;EFV:NLI;SFV:NSPM;SFS:(6009001)(428002)(53754006)(377454003)(164054003)(24454002)(584324002)(51704005)(83716003)(15974865002)(92566002)(2950100001)(2900100001)(102836002)(15975445007)(53416004)(110136001)(50986999)(36756003)(86362001)(62966003)(77156002)(450100001)(50466002)(23746002)(82746002)(6806004)(33656002)(2171001)(19580395003)(106466001)(19580405001)(54356999)(66066001)(76176999)(101416001)(47776003)(87836001)(106116001)(74482002)(46102003)(105586002)(2656002)(561944003)(7059030)(104396002);DIR:INB;SFP:;SCL:1;SRVR:BY2PR0201MB0837;H:vmaprod6.mail-relay.ubc.ca;FPR:;SPF:None;MLV:sfv;LANG:en;
X-MS-Exchange-Organization-Network-Message-Id: 6e5df956-d633-43af-a2bd-08d2194eaf23
X-Microsoft-Antispam: UriScan:;
X-Microsoft-Antispam: BCL:0;PCL:0;RULEID:;SRVR:BY2PR0201MB0837;
X-MS-Exchange-Organization-AVStamp-Service: 1.0
X-Exchange-Antispam-Report-Test: UriScan:;
X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:(601004);SRVR:BY2PR0201MB0837;
X-MS-Exchange-Organization-SCL: 1
X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:;SRVR:BY2PR0201MB0837;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 18 Feb 2015 04:58:34.3965
 (UTC)
X-MS-Exchange-CrossTenant-Id: a8216c1e-4d63-4352-8c3b-50fa1f1475b1
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BY2PR0201MB0837
X-MS-Exchange-Organization-AuthSource: BN1AFFO11FD028.protection.gbl
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.2762825

------=_NextPart_43787348.329277678517
Content-Type: text/plain;
 charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Hi all,

The key meeting is the face-to-face meeting May 27-29.  It probably will be=
 in Toronto and it would be great if you all could make that.  The others a=
re not as critical, although Genome BC likes to make it sound like they are=
 life and death.

Thanks, Loren



On Feb 17, 2015, at 5:09 PM, David Charest <dcharest@genomebc.ca> wrote:

> Dear Loren and John,
> 
> I hope work on the full application is progressing well.   Even though yo=
u are still a few weeks away from the March 9 deadline for the first comple=
te draft, it is important that you look ahead to, and plan for, some the cr=
itical dates following that deadline.  Please reserve the following days in=
 your calendar =E2=80=94and make sure key team members not included on this=
 email do the same:
> 
> March 25-26  [Reviewer feedback]  Face-to-face meeting at Genome BC.   Fo=
llowing submission of your draft to Genome BC on March 9th we will send it =
out to reviewers to get some feedback on your proposal which we will pass o=
n to you on or about  ~March 20.  As the meeting on March 25-26  we will re=
view with you the feedback from the reviewers and work with you to address =
any deficiencies in the proposal and enhance its strengths.  Participants i=
n this meeting should include: Pis and key science leads, the GELS lead, in=
dustry/user representation and the project manager with which you are worki=
ng.
> 
> May 14/15 [Mock panel review] Face-to-face meeting at Genome BC.  In this=
 meeting 4-5 key members of the team (2PI s, GELS lead and industry Rep/End=
 User/key co-applicants/Project Manager depending on number of participants=
 allowed) will undergo a Panel simulation in preparation for the Genome Can=
ada Panel Review two weeks later.
> 
> May 27-29 [Genome Canada Panel Review] Face-to-face meeting outside BC (T=
BD) In this meeting 4-5 key members of the team (as above) and Genome BC pe=
rsonel will travel outside BC (TBD) for the formal Panel Review with Genome=
 Canada.
> 
> The May 27/29 dates are fixed (we are not sure which day it will be yet, =
but it will be one of those three). If key personnel in your team have any =
major conflicts please let us know immediately.
> 
> Alison Dendoff (adendoff@genomebc.ca) and team will be in contact nearer =
these dates with more information.
> 
> Best regards
> 
> David
> 
> 
> 
> David CHAREST Ph.D.
> Director, Sector Development
> Genome British Columbia
> 400 - 575 West 8th Avenue, Vancouver, BC V5Z 1C6
> Tel: 604-637-4387 Mobile: 604-779-6261 Fax: 604-738-8597
> dcharest@genomebc.ca<mailto:dcharest@genomebc.ca> - www.genomebc.ca<http:=
//www.genomebc.ca/>
> 
> "A catalyst for a vibrant genomics-driven- life sciences cluster on Canad=
a's West Coast"

Loren Rieseberg
Botany Department
University of British Columbia
3529-6270 University Blvd
Vancouver, B.C. V6T 1Z4
Phone: 604-827-4540
Fax: 604-822-6089


------=_NextPart_43787348.329277678517
Content-Type: text/rtf;
 charset="utf-8"
Content-Transfer-Encoding: quoted-printable

{\rtf1\ansi\ansicpg1252\fromtext \fbidis \deff0{\fonttbl=0A=0D{\f0\fswiss\f=
charset0 Arial;}=0A=0D{\f1\fmodern Courier New;}=0A=0D{\f2\fnil\fcharset2 S=
ymbol;}=0A=0D{\f3\fmodern\fcharset0 Courier New;}}=0A=0D{\colortbl\red0\gre=
en0\blue0;\red0\green0\blue255;}=0A=0D\uc1\pard\plain\deftab360 \f0\fs20 Hi=
 all,\par=0A=0D\par=0A=0DThe key meeting is the face-to-face meeting May 27=
-29.  It probably will be in Toronto and it would be great if you all could=
 make that.  The others are not as critical, although Genome BC likes to ma=
ke it sound like they are life and death.\par=0A=0D\par=0A=0DThanks, Loren\=
par=0A=0D\par=0A=0D\par=0A=0D\par=0A=0DOn Feb 17, 2015, at 5:09 PM, David C=
harest <dcharest@genomebc.ca> wrote:\par=0A=0D\par=0A=0D> Dear Loren and Jo=
hn,\par=0A=0D> \par=0A=0D> I hope work on the full application is progressi=
ng well.   Even though you are still a few weeks away from the March 9 dead=
line for the first complete draft, it is important that you look ahead to, =
and plan for, some the critical dates following that deadline.  Please rese=
rve the following days in your calendar \'97and make sure key team members =
not included on this email do the same:\par=0A=0D> \par=0A=0D> March 25-26 =
 [Reviewer feedback]  Face-to-face meeting at Genome BC.   Following submis=
sion of your draft to Genome BC on March 9th we will send it out to reviewe=
rs to get some feedback on your proposal which we will pass on to you on or=
 about  ~March 20.  As the meeting on March 25-26  we will review with you =
the feedback from the reviewers and work with you to address any deficienci=
es in the proposal and enhance its strengths.  Participants in this meeting=
 should include: Pis and key science leads, the GELS lead, industry/user re=
presentation and the project manager with which you are working.\par=0A=0D>=
 \par=0A=0D> May 14/15 [Mock panel review] Face-to-face meeting at Genome B=
C.  In this meeting 4-5 key members of the team (2PI s, GELS lead and indus=
try Rep/End User/key co-applicants/Project Manager depending on number of p=
articipants allowed) will undergo a Panel simulation in preparation for the=
 Genome Canada Panel Review two weeks later.\par=0A=0D> \par=0A=0D> May 27-=
29 [Genome Canada Panel Review] Face-to-face meeting outside BC (TBD) In th=
is meeting 4-5 key members of the team (as above) and Genome BC personel wi=
ll travel outside BC (TBD) for the formal Panel Review with Genome Canada.\=
par=0A=0D> \par=0A=0D> The May 27/29 dates are fixed (we are not sure which=
 day it will be yet, but it will be one of those three). If key personnel i=
n your team have any major conflicts please let us know immediately.\par=0A=
=0D> \par=0A=0D> Alison Dendoff (adendoff@genomebc.ca) and team will be in =
contact nearer these dates with more information.\par=0A=0D> \par=0A=0D> Be=
st regards\par=0A=0D> \par=0A=0D> David\par=0A=0D> \par=0A=0D> \par=0A=0D> =
\par=0A=0D> David CHAREST Ph.D.\par=0A=0D> Director, Sector Development\par=
=0A=0D> Genome British Columbia\par=0A=0D> 400 - 575 West 8th Avenue, Vanco=
uver, BC V5Z 1C6\par=0A=0D> Tel: 604-637-4387 Mobile: 604-779-6261 Fax: 604=
-738-8597\par=0A=0D> dcharest@genomebc.ca<mailto:dcharest@genomebc.ca> - ww=
w.genomebc.ca<http://www.genomebc.ca/>\par=0A=0D> \par=0A=0D> "A catalyst f=
or a vibrant genomics-driven- life sciences cluster on Canada's West Coast"=
\par=0A=0D\par=0A=0DLoren Rieseberg\par=0A=0DBotany Department\par=0A=0DUni=
versity of British Columbia\par=0A=0D3529-6270 University Blvd\par=0A=0DVan=
couver, B.C. V6T 1Z4\par=0A=0DPhone: 604-827-4540\par=0A=0DFax: 604-822-608=
9\par=0A=0D\par=0A=0D}
------=_NextPart_43787348.329277678517--